Skip to content

    Crinetics Pharmaceuticals (CRNX) stock price & financials

    View CRNX earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+179.1% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $0
    $0
    $361.0K
    $1.03M
    $143.0K
    $6.16M
    $10.73M
    +2873.4%
    $25.12M
    +2336.3%
    Strengthening
    Operating Profit
    -$87.80M
    -$94.75M
    -$111.41M
    -$129.11M
    -$142.59M
    -62.4%
    -$133.67M
    -41.1%
    -$140.38M
    -26.0%
    -$132.46M
    -2.6%
    Weakening
    Net Profit
    -$76.83M
    -$80.59M
    -$96.77M
    -$115.64M
    -$130.09M
    -69.3%
    -$122.81M
    -52.4%
    -$127.84M
    -32.1%
    -$120.86M
    -4.5%
    Weakening
    EPS
    $-0.96
    $-1.04
    $-1.23
    $-1.38
    -43.7%
    $-1.23
    -18.3%
    $-1.14
    +7.3%
    Weakening
    Other Income
    $10.97M
    $14.15M
    $14.63M
    $13.47M
    $12.49M
    +13.9%
    $11.03M
    -22.0%
    $12.53M
    -14.3%
    $11.60M
    -13.9%
    Weakening
    Interest
    Depreciation
    Profit before Tax
    -$76.83M
    -$130.09M
    -69.3%
    MarginsOPM
    -30860.1%
    -12523.0%
    -99710.5%
    -2169.6%
    -1307.8%
    +95.8%
    -527.4%
    +95.8%
    Strengthening
    Tax
    ReturnsROIC
    -6.4%
    -6.7%
    -8.1%
    -9.7%
    -10.9%
    -69.3%
    -10.3%
    -52.4%
    -10.7%
    -32.1%
    -10.1%
    -4.5%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$44.97M$40.33M$93.09M$200.69M$32.67M$54.90M$264.55M$101.54M$55.50M
    Short-Term Investments
    Total Current Assets$166.68M$123.34M$177.49M$344.72M$345.18M$574.15M$1.38B$1.05B$1.24B
    Net PP&E$4.23M$6.46M$5.41M$4.72M$4.99M$57.43M$55.58M$54.79M$52.18M
    Goodwill
    Intangibles
    Total Assets$171.41M$130.38M$183.44M$351.01M$352.18M$635.35M$1.43B$1.13B$1.32B
    LiabilitiesTotal Current Liabilities$7.92M$8.34M$10.49M$15.99M$27.72M$43.94M$59.68M$85.07M$79.92M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$4.85M$4.01M$3.07M$2.02M$47.55M$44.57M$42.05M$40.61M
    Total Liabilities$11.19M$13.24M$14.53M$19.07M$35.85M$96.25M$109.79M$134.17M$129.92M
    EquityCommon Stock & APIC$203.54M$210.79M$336.51M$607.58M$759.43M$1.19B$2.28B$2.41B$2.86B
    Retained Earnings-$43.38M-$93.80M-$167.61M-$275.25M-$439.17M-$653.70M-$952.11M-$1.42B-$1.67B
    Total Equity$160.22M$117.14M$168.92M$331.94M$316.33M$539.11M$1.32B$992.08M$1.19B
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$19.46M-$46.38M-$62.03M-$88.59M-$115.20M-$168.60M-$230.19M-$377.92M-$422.51M
    Cash from Investing-$119.46M$41.67M$217.0K-$56.48M-$173.98M-$200.41M-$574.82M$173.91M-$4.15M
    Cash from Financing$170.20M$67.0K$114.57M$252.68M$121.96M$391.24M$1.01B$40.61M$427.92M
    SummaryCapital Expenditure-$1.06M-$492.0K-$186.0K-$436.0K-$1.66M-$4.69M-$3.84M-$5.76M-$2.66M
    Free Cash Flow-$20.52M-$46.87M-$62.21M-$89.02M-$116.86M-$173.29M-$234.04M-$383.68M-$425.18M
    FCF Margin-845.1%-3929.0%-87623.9%-8258.3%-2467.0%-4318.1%-22525.3%-4985.5%-1008.6%

    Ratios